CONCENTRIX CORP's ticker is CNXC and the CUSIP is 20602D101. A total of 318 filers reported holding CONCENTRIX CORP in Q2 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $276,534 | +15.8% | 4,370 | +21.2% | 0.00% | +33.3% |
| Q1 2024 | $238,789 | -19.0% | 3,606 | +20.2% | 0.00% | -25.0% |
| Q4 2023 | $294,728 | -4.6% | 3,001 | -22.2% | 0.00% | -20.0% |
| Q3 2023 | $308,824 | -0.7% | 3,855 | +0.1% | 0.01% | 0.0% |
| Q2 2023 | $310,968 | -43.9% | 3,851 | -15.6% | 0.01% | -44.4% |
| Q1 2023 | $554,755 | +176.1% | 4,564 | +202.5% | 0.01% | +200.0% |
| Q4 2022 | $200,938 | -7.4% | 1,509 | -5.7% | 0.00% | -25.0% |
| Q2 2022 | $217,000 | -17.2% | 1,601 | +1.8% | 0.00% | 0.0% |
| Q1 2022 | $262,000 | -75.7% | 1,572 | -74.0% | 0.00% | -71.4% |
| Q4 2021 | $1,079,000 | -3.1% | 6,042 | -3.9% | 0.01% | -12.5% |
| Q3 2021 | $1,113,000 | +13.5% | 6,285 | +3.0% | 0.02% | +14.3% |
| Q2 2021 | $981,000 | +9.0% | 6,104 | +1.6% | 0.01% | 0.0% |
| Q1 2021 | $900,000 | +92.3% | 6,010 | +26.9% | 0.01% | +75.0% |
| Q4 2020 | $468,000 | – | 4,736 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Groupe Bruxelles Lambert | 8,773,667 | $555,197,648 | 100.00% |
| Impactive Capital LP | 3,846,370 | $243,398,294 | 9.46% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 623,542 | $39,457,738 | 1.80% |
| LYRICAL ASSET MANAGEMENT LP | 1,271,250 | $80,444,700 | 1.29% |
| Copeland Capital Management, LLC | 985,722 | $62,376,533 | 1.17% |
| Nierenberg Investment Management Company, Inc. | 27,910 | $1,766,145 | 0.99% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 564,732 | $35,736,207 | 0.97% |
| VALLEY WEALTH MANAGERS, INC. | 168,482 | $10,661,541 | 0.85% |
| Bragg Financial Advisors, Inc | 202,698 | $12,826,730 | 0.57% |
| CLARK ESTATES INC/NY | 44,250 | $2,800,140 | 0.53% |